Clinical Trials in Arizona

Showing 6201-6220 of 16,770 trials

The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.

NCT02174250

The purpose of this study is to test whether Rifampin affects blood levels of istradefylline in humans. Rifampin could possibly decrease istradefylline levels.

Parkinson's Disease

Kyowa Kirin Co., Ltd.20 participantsStarted Jun 2014

Tempe, Arizona, United States

COMPLETEDPhase 342 miles

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

NCT01906866

The purpose of this study is to establish the efficacy and safety of Circadin in children with neurodevelopmental disorders and to determine the dose, this randomized, placebo-controlled study is planned to evaluate the efficacy of a double-blind, 13 week treatment period with Circadin 2/5mg in improving maintenance of sleep, sleep latency and additional parameters in children with neurodevelopmental disabilities. The efficacy and safety of Circadin 2/5 mg will continue to be assessed during an open-label extension period of 13 weeks.

Sleep Disorders

Neurim Pharmaceuticals Ltd.125 participantsStarted Oct 2013

Phoenix, Arizona, United States • Miami Lakes, Florida, United States • Orange City, Florida, United States +25 more locations

The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

Find Trials by Condition in Arizona

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

Identification of Novel Molecular Markers for Vasospasm

PRS-343 in HER2-Positive Solid Tumors

The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

A Study Of PF-04449913 In Select Hematologic Malignancies

Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment

A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

LYT-100 in Patients With BCRL

Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer

Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma

Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus

PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants

Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility